Timothy Aksamit is a Respiratory physician. OpenAlex indexes 187 publications with 12,492 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 11 Aug 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20242 payments
- Zambon USA Ltd.Program year20241 payment
- Insmed, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
55.1%Antimycobacterial11.2%Ethambutol Hcl100%Part D<11 patientsPolymyxin-class Antibacterial9.3%Colistimethate100%Part D<11 patients+ 5 more classes in this area
Respiratory
24.6%beta2-Adrenergic Agonist16.6%Albuterol Sulfate Hfa100%Part D≥30 patientsCorticosteroid8%Fluticasone Propionate58%Breo Ellipta42%Part D<11 patientsMetabolism & gastrointestinal
20.2%H2 blocker12.4%Famotidine100%Part D≥18 patientsProton pump inhibitor5.1%Omeprazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Digitalization of health care in low- and middle-income countries
Bulletin of the World Health Organization
2025 - Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients
American Journal of Respiratory and Critical Care Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”